Identification of stable reference genes and differential miRNA expression in Sri Lankan type 2 diabetes mellitus patients: a cross-sectional study

1Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

Abstract

Introduction: Type 2 Diabetes mellitus is a major global health concern. MicroRNA plays an important role in regulating pancreatic beta cells as well as peripheral insulin signaling. This study aimed to identify reference microRNA s in type 2 Diabetes mellitus plasma and validate two target microRNAs among a Sri Lankan population with type 2 diabetes mellitus. Methods: This is a cross-sectional experiment. A total of fifty-three (N = 53) non-hemolyzed plasma samples from individuals with type 2 diabetes mellitus were selected to evaluate stability, in comparison to thirty-eight (N = 38) normoglycemic non-hemolyzed plasma samples. Initially, the stability of four candidate reference microRNAs (hsa-miR-16-5p, hsa-miR-425-5p, hsa-miR-191-5p, and hsa-miR-22-5p) was assessed. Stability was analyzed using the geNorm and BestKeeper algorithms. The relative expression changes of hsa-miR-29a-3p and hsa-miR-375-3p in the plasma of the same samples were evaluated using the validated reference microRNAs. The selected regulatory microRNAs were directly linked with type 2 diabetes mellitus pathogenesis and proved to be upregulated in type 2 diabetes mellitus plasma and serum. Results and discussion: The expressions of miR-16-5p and miR-191-5p were not stable between the two groups, miR-22-5p and miR-425-5p levels were found to be stable. A significant upregulation of hsa-miR-29a-3p and hsa-miR-375-3p was observed in type 2 diabetes mellitus patients compared to normoglycemic individuals (p ≤ 0.05). This was the first study to claim hsa-miR-425-5p and hsa-miR-22-5p as stably expressed reference microRNAs in type 2 diabetes mellitus patients. Sri Lankan type 2 diabetic patients also had increased hsa-miR-29a-3p and hsa-miR-375-3p levels. However, large and well-matched sample studies were suggested to ensure that these microRNAs can be used as type 2 diabetes diagnostic markers in Sri Lanka.

Cite

CITATION STYLE

APA

Palihaderu, P. A. D. S., Mendis, B. I. L. M., Premarathne, J. M. K. J. K., Dias, W. K. R., Yeap, S. K., Ho, W. Y., … Satharasinghe, D. A. (2025). Identification of stable reference genes and differential miRNA expression in Sri Lankan type 2 diabetes mellitus patients: a cross-sectional study. Frontiers in Endocrinology, 16. https://doi.org/10.3389/fendo.2025.1554827

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free